Larvol Delta - ECLIPSE-2-A-Study-to-Evaluate-TobevibartElebsiran-in-Participants-With-Chronic-HDV-Infection-Not-Virologically-Suppressed-With-Bulevirtide

tobevibart (VIR-3434) - Vir Biotech

elebsiran (VIR-2218) - Alnylam, Vir Biotech

Hepcludex (bulevirtide) - Gilead

http://clinicaltrials.gov/ct2/show/NCT07128550

May 7, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next